Search Results - "Daniel Milton"

Improving Tests of Theories Positing Interaction by Berry, William D., Golder, Matt, Milton, Daniel

“…It is well established that all interactions are symmetric: when the effect of X on Y is conditional on the value of Z, the effect of Z must be conditional on…”
Get full text

Examining the Outcome of Investigations and Prosecutions of Extremism in the United States by Yon, Rachel, Milton, Daniel

“…While the criminology literature indicates that investigative and judicial outcomes can be influenced by several factors, a smaller number of scholars have…”
Get full text

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy by KEEDY, Vicki Leigh, TEMIN, Sarah, SOMERFIELD, Mark R, BEASLEY, Mary Beth, JOHNSON, David H, MCSHANE, Lisa M, MILTON, Daniel T, STRAWN, John R, WAKELEE, Heather A, GIACCONE, Giuseppe

“…An American Society of Clinical Oncology (ASCO) provisional clinical opinion (PCO) offers timely clinical direction to ASCO's membership following publication…”
Get full text

Strength from the Shadows? How Shadow Economies Affect Terrorist Activities by Jadoon, Amira, Milton, Daniel

“…Despite scholarly interest in the existence and consequences of the crime-terror nexus, little research has been done to examine how the presence of an illegal…”
Get full text

Needs or Symbols? The Logic of United Nations Counterterrorism Treaty Ratification by Milton, Daniel, Jadoon, Amira, Warner, Jason

“…Abstract Why do states commit to UN counterterrorism treaties? This article posits that state accession to UN counterterrorism treaties is likely informed by…”
Get full text

Choosing to Fight, Choosing to Die: Examining How ISIS Foreign Fighters Select Their Operational Roles by Evans, Tyler, Milton, Daniel J, Young, Joseph K

“…Understanding why and how individuals participate in militant organizations has been the focus of an increasing amount of scholarship. Traditionally, these…”
Get full text

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer by Christopher G. Azzoli, Sherman Baker, Jr, Sarah Temin, William Pao, Timothy Aliff, Julie Brahmer, David H. Johnson, Janessa L. Laskin, Gregory Masters, Daniel Milton, Luke Nordquist, David G. Pfister, Steven Piantadosi, Joan H. Schiller, Reily Smith, Thomas J. Smith, John R. Strawn, David Trent, Giuseppe Giaccone

“…The purpose of this article is to provide updated recommendations for the treatment of patients with stage IV non-small-cell lung cancer. A literature search…”
Get full text

Double Space Augmentation Mastopexy—A Reflection After 15 Years by Graça Neto, Lincoln, Daniel, Milton

“…Introduction The treatment of breast ptosis using mastopexy associated with the inclusion of a silicone prosthesis in a single surgical procedure is a…”
Get full text

Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer by PATEL, Jyoti D, HENSING, Thomas A, RADEMAKER, Alfred, HART, Eric M, BLUM, Matthew G, MILTON, Daniel T, BONOMI, Philip D

“…This study evaluated the efficacy and safety of pemetrexed, carboplatin, and bevacizumab followed by maintenance pemetrexed and bevacizumab in patients with…”
Get full text

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer by AZZOLI, Christopher G, TEMIN, Sarah, PAO, William, PFISTER, David G, PIANTADOSI, Steven, SCHILLER, Joan H, SMITH, Reily, SMITH, Thomas J, STRAWN, John R, TRENT, David, GIACCONE, Giuseppe, ALIFF, Timothy, BAKER, Sherman, BRAHMER, Julie, JOHNSON, David H, LASKIN, Janessa L, MASTERS, Gregory, MILTON, Daniel, NORDQUIST, Luke

“…An American Society of Clinical Oncology (ASCO) focused update updates a single recommendation (or subset of recommendations) in advance of a regularly…”
Get full text

Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus by RIELY, Gregory J, KRIS, Mark G, MILLER, Vincent A, BINSHENG ZHAO, AKHURST, Tim, MILTON, Daniel T, MOORE, Erin, TYSON, Leslie, PAO, William, RIZVI, Naiyer A, SCHWARTZ, Lawrence H

“…Purpose: Ten percent of U.S. patients with non–small cell lung cancer experience partial radiographic responses to erlotinib or gefitinib. Despite initial…”
Get full text

Dangerous work: Terrorism against U.S. diplomats by Milton, Daniel J.

“…The goal of diplomats is to represent their countries' interests through diplomacy, not arms. Because they are not military personnel, they may be perceived as…”
Get full text

Justicia Juvenil Restaurativa: Tendencias Actuales y su Impacto en la Sociedad by Milton Daniel Calle Tapia

“…Históricamente, el manejo de adolescentes infractores ha sido un desafío. Por tal razón, este artículo académico pretende exponer cómo la justicia juvenil…”
Get full text

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib by Omuro, Antonio M. P., Kris, Mark G., Miller, Vincent A., Franceschi, Enrico, Shah, Neelam, Milton, Daniel T., Abrey, Lauren E.

“…BACKGROUND Gefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor that induces an early and dramatic response in 10% of patients with…”
Get full text

A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer by Milton, Daniel T., Azzoli, Christopher G., Heelan, Robert T., Venkatraman, Ennapadam, Gomez, Jorge E., Kris, Mark G., Krug, Lee M., Pao, William, Rizvi, Naiyer A., Dunne, Megan, Miller, Vincent A.

“…BACKGROUND. Preclinical studies have suggested that erlotinib at high doses may inhibit additional sites downstream of the epidermal growth factor receptor…”
Get full text

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer by Milton, Daniel T., Riely, Gregory J., Azzoli, Christopher G., Gomez, Jorge E., Heelan, Robert T., Kris, Mark G., Krug, Lee M., Pao, William, Pizzo, Barbara, Rizvi, Naiyer A., Miller, Vincent A.

“…BACKGROUND. Preclinical studies have demonstrated that the inhibition of the PI3K/Akt/mTOR pathway restores gefitinib sensitivity in resistant cancer cell…”
Get full text

Unpacking the Connection Between Terror and Islam by Conrad, Justin, Milton, Daniel

“…Are countries with large Muslim populations more likely to experience or produce transnational terrorist attacks than countries with fewer Muslims? And if…”
Get full text

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence by Slingluff, Craig L, Lewis, Karl D, Andtbacka, Robert, Hyngstrom, John, Milhem, Mohammed, Markovic, Svetomir N, Bowles, Tawnya, Hamid, Omid, Hernandez-Aya, Leonel, Claveau, Joel, Jang, Sekwon, Philips, Prejesh, Holtan, Shernan G, Shaheen, Montaser F, Curti, Brendan, Schmidt, William, Butler, Marcus O, Paramo, Juan, Lutzky, Jose, Padmanabhan, Arvinda, Thomas, Sajeve, Milton, Daniel, Pecora, Andrew, Sato, Takami, Hsueh, Eddy, Badarinath, Suprith, Keech, John, Kalmadi, Sujith, Kumar, Pallavi, Weber, Robert, Levine, Edward, Berger, Adam, Bar, Anna, Beck, J Thaddeus, Travers, Jeffrey B, Mihalcioiu, Catalin, Gastman, Brian, Beitsch, Peter, Rapisuwon, Suthee, Glaspy, John, McCarron, Edward C, Gupta, Vinay, Behl, Deepti, Blumenstein, Brent, Peterkin, Joanna J

“…BackgroundMost patients with advanced melanomas relapse after checkpoint blockade therapy. Thus, immunotherapies are needed that can be applied safely early,…”
Get full text

Escuela y despojo: la situación de la escuela rural en el marco del conflicto armado en Colombia by Blandón Giraldo, Alba Mery, Castellano Ascencio, Milton Daniel

“…Las principales posturas teóricas que han abordado la situación de la escuela rural en el marco del conflicto armado en Colombia presenten comprensiones…”
Get full text

Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non–Small-Cell Lung Cancer by RIELY, Gregory J, RIZVI, Naiyer A, SESHAN, Venkatraman E, FOGLE, Margaret, GINSBERG, Michelle, MILLER, Vincent A, RUDIN, Charles M, KRIS, Mark G, MILTON, Daniel T, SOLIT, David B, ROSEN, Neal, SENTURK, Emir, AZZOLI, Christopher G, BRAHMER, Julie R, SIROTNAK, Francis M

“…A prior study demonstrated that addition of continuous daily erlotinib fails to improve response rate or survival in non-small-cell lung cancer (NSCLC)…”
Get full text